TGFB1 and fibrosis: This evidence suggests that circRNA_0004104 could promote cardiac fibrosis by targeting MAPK and TGF-β signaling pathways, and that elevating the circRNA_0004104 0004104 expressions can be a potential strategy to treat the f cardiac fibrosis and persistent AF (Gao et al., 2021).